Avadel Pharmaceuticals plc - ADR

NASDAQ:AVDL  
2.52
+1.45 (+135.51%)
5:10:07 PM EDT: $2.46 -0.06 (-2.38%)
Earnings Announcements

Avadel Pharmaceuticals Provides Corporate Update, Reports Q4 Results

Published: 03/17/2022 11:20 GMT
Avadel Pharmaceuticals plc - ADR (AVDL) - Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results.
Q4 Loss per Share $0.38.
Cash, Cash Equivalents and Marketable Securities Were $157.2 Million As of December 31, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.44

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.